Magnocurarine
CAS No. 6801-40-7
Magnocurarine( —— )
Catalog No. M21688 CAS No. 6801-40-7
Magnocurarine is a natural product from Magnolia officinalis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 620 | In Stock |
|
| 5MG | 595 | In Stock |
|
| 10MG | 844 | In Stock |
|
| 25MG | 1264 | In Stock |
|
| 50MG | 1665 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMagnocurarine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMagnocurarine is a natural product from Magnolia officinalis.
-
DescriptionMagnocurarine is a natural product from Magnolia officinalis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6801-40-7
-
Formula Weight314.4
-
Molecular FormulaC19H24NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[N+](C)(CCc1c2)[C@H](Cc(cc3)ccc3O)c1cc(O)c2OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Effect of Chemical Profiling Change of Processed Magnolia officinalis on the Pharmacokinetic Profiling of Honokiol and Magnolol in Rats.J Chromatogr Sci. 2016 Aug;54(7):1201-12.
molnova catalog
related products
-
MYLS22
MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
-
BCAT-IN-4
BCAT-IN-4 is a potent BCAT inhibitor with an IC50 value of 2.35 μM for hBCATc. BCAT-IN-4 has anticancer activity and can be used to study pancreatic ductal adenocarcinoma.
-
Abelacimab
Abelacimab (MAA868), a fully human IgG1 monoclonal antibody, targets and binds with high affinity to FXI's catalytic structural domain.
Cart
sales@molnova.com